BioSpectrum India: BioPharma, Healthcare, healthscience, Biotechnology, BioIT, Pharma news updates

SCIENCE

Science | 28 November 2022 | News

Karnataka State Council for Science and Technology receives special recognition

Karnataka Government has announced that more than 700 patents have been filed by Karnataka State Council for S...Read more

OPINION

Opinion | 26 November 2022 | Views

How can the pharma industry save billions of dollars every year?

With more than 300,000 people employed in the pharmaceutical industry alone, there is no shortage of opportuni...Read more

MEDTECH

MedTech | 18 November 2022 | News

Swedish medtech firm C-RAD sets up India Experience Centre for Precision Radiotherapy

Swedish medtech company C-RAD, the global leader in surface guided radiation therapy (SGRT) solutions, has est...Read more

START-UPS

Start-ups | 25 November 2022 | News

Redcliffe Labs to invest $10 M for expanding genetics & specialised testing capabilities

Noida-based startup Redcliffe Labs plans to invest further $10 million towards the expansion of its genetic an...Read more

SUPPLIER

Supplier | 22 November 2022 | News

West introduces gamma irradiated flip-off seals in Indian market

West Pharmaceutical Services, Inc. has recently expanded its seal offerings by launching Gamma Irradiated...Read more

PEOPLE

People | 29 November 2022 | News

MSD India appoints Bhargavi Kakunuri as Human Resources Lead

MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) has announced Bhargavi Kakunuri’ s appointme...Read more

ACADEMICS

Academics | 29 November 2022 | News

IIM Raipur inks MoU with Digital Health Academy for launching new online course

A Memorandum of Understanding (MoU) has been signed between Digital Health Academy (an SBU of Digital Health A...Read more

BLOGS

Blogs | 08 May 2022 | Views

Returning Mothers: Upskilling Their Way in Their Career

Whether you are a mother who has been out of the workplace for one year or ten years, the thought of restartin...Read more

Videos

Inside Magazine

Can INDIA Dethrone CHINA In API PRODUCTION?

The past decade has witnessed steady growth and commitment of the Indian government in addressing issues like ‘self-reliance and self-sufficiency in all aspects of governance and decisions. While sops and subsidies were, indeed, crucial to many concerns of industries and stakeholders, key decisions and schemes were lacking, until numerous ‘Aatmanirbhar Projects’ were kicked off by the Centre. One such crucial initiative addresses the need for Bulk Drugs Parks in India, making the country less dependent on Chinese Active Pharmaceutical Ingredients (APIs), providing more employment, and generating more revenue that will add to the country’s GDP. A laudable step has been taken with the launching of three Bulk Drugs projects across three states in the country, with an estimated time of completion set at 5 years. We shall take a closer look at what the project entails and seek expert views from a few industry stalwarts.

For Feedback, please email us at: communications@mmactiv.com